Zydus Lifesciences (ZYDUSLIFE) Share Price Falls 2.17% as Bernstein Turns Positive
- September 9, 2026
- Posted by: Kunal Singla
- Category: News
Zydus Lifesciences Share Price was at Rs 1,129, down 2.17% from the previous close of Rs 1,154, with market capitalisation at Rs 1,15,710.44 crore. Zydus Lifesciences Share Price moved lower in a Large Cap healthcare counter after trading between Rs 1,165 and Rs 1,129 in the current move, with the day open at Rs 1,164.95. According to latest Univest figures, Zydus Lifesciences Share Price is drawing attention because the decline comes alongside a detailed fundamental profile: P/E of 25.51, P/B of 4.27, ROE of 19.69%, ROCE of 21.39%, EPS of Rs 45.24 and book value of Rs 270.31. In Univest analysis, the stock’s current market setting is best read through price action, valuation and sector comparison rather than any unsupported trigger.
Zydus Lifesciences (ZYDUSLIFE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,129 |
| Previous Close | Rs 1,154 |
| Today's Move | -Rs 25.00 (-2.17%) |
| Open | Rs 1,164.95 |
| High | Rs 1,165 |
| Low | Rs 1,129 |
| Market Capitalisation | Rs 1,15,710.44 crore |
| Market Cap Category | Large Cap |
Zydus Lifesciences Share Price today shows a clear intraday decline of Rs 25, or 2.17%, from the previous close. The stock opened at Rs 1,164.95, touched a high of Rs 1,165 and a low of Rs 1,129, which is also the current price. That means Zydus Lifesciences Share Price is trading at the day’s low as of 08 October 2026 at 10:23:01 AM IST. The move is relevant because the stock is a Large Cap with a market capitalisation of Rs 1,15,710.44 crore, so even a moderate percentage change alters a very large equity value base. For readers tracking Zydus Lifesciences Share Price Today, the key facts are the gap from the previous close, the narrow high-low band and the lower print now visible in the market. This price action sets up the broader question behind Zydus Lifesciences Share Price and its fundamental context.
Why Zydus Lifesciences (ZYDUSLIFE) May Be Moving Today
Zydus Lifesciences (ZYDUSLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,15,710.44 crore |
| P/E Ratio | 25.51x |
| P/B Ratio | 4.27x |
| ROE | 19.69% |
| ROCE | 21.39% |
| EPS | Rs 45.24 |
| Book Value Per Share | Rs 270.31 |
| Dividend Yield | 0.09% |
Zydus Lifesciences (ZYDUSLIFE) fundamental metrics show P/E 25.51x, P/B 4.27x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.
Zydus Lifesciences has a market capitalisation of Rs 1,15,710.44 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.51x, P/B at 4.27x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.51x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 4.27x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 19.69% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 21.39% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 1,15,710.44 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Zydus Lifesciences (ZYDUSLIFE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Zydus Lifesciences (ZYDUSLIFE) has a P/E ratio of 25.51x, which is below the benchmark median of 31.87x, a difference of -19.96%. On its own, the P/E gap is a valuation reference point, not a trading call.
Zydus Lifesciences (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.61%, a difference of +69.6%. Zydus Lifesciences (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.46%, a difference of +58.92%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
| Cipla | CIPLA | 1,08,497.02 | 31.87 | 3.06 | 11.83 | 16 |
Zydus Lifesciences (ZYDUSLIFE) has a P/E ratio of 25.51x compared with the displayed peer median of 82.14x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 19.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Zydus Lifesciences (ZYDUSLIFE) has a market capitalisation of Rs 1,15,710.44 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Zydus Lifesciences
- Zydus Lifesciences Share Price is down 2.17% today, so the intraday move itself is a key focus.
- The company’s P/E of 25.51 is below the industry median, which keeps Zydus Lifesciences Share Price in valuation comparison mode.
- ROE of 19.69% and ROCE of 21.39% show a stronger return profile than many healthcare names.
- Market capitalisation of Rs 1,15,710.44 crore makes every percentage move meaningful for Zydus Lifesciences Share Price.
- Bernstein’s Outperform note on Zydus Life was published on the same day and is part of Zydus Lifesciences Stock News.
About Zydus Lifesciences
Zydus Lifesciences operates in the Pharmaceuticals & Drugs industry within Healthcare. The business is known for pharmaceutical products and commercialization capabilities, and it sits among large listed companies in the sector. For Zydus Lifesciences Share Price readers, the company context matters because the stock is influenced by both business execution and sector-wide valuation norms. The latest Univest view places Zydus Lifesciences Share Price inside a broad healthcare universe where peers differ sharply on scale, multiples and return ratios. That makes Zydus Lifesciences Stock Analysis relevant not only for price movement but also for how the company compares with other listed drug makers.
Track Zydus Lifesciences Share Price on Univest
Use Zydus Lifesciences (ZYDUSLIFE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Track Zydus Lifesciences Share Price on Univest to review live price movement, fundamental ratios, 52-week levels and broader market insights in one place. The platform helps readers follow Zydus Lifesciences Share Price Today, compare valuation with peers and monitor healthcare sector context without adding noise.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Zydus Lifesciences Share Price fall today?
Ans. Zydus Lifesciences Share Price fell 2.A Bernstein report was published the same day and may be relevant for readers tracking the move.
What is the current Zydus Lifesciences Share Price?
Ans. Zydus Lifesciences Share Price was at Rs 1,129, compared with the previous close of Rs 1,154. The stock traded between Rs 1,165 and Rs 1,129 in the current move, keeping the intraday range tight.
How much did Zydus Lifesciences Share Price change today?
Ans. Zydus Lifesciences Share Price declined by Rs 25, or 2.17%, from the previous close. That makes it a clear share price fall in a Large Cap healthcare name with a market capitalisation above Rs 1,15,000 crore.
What is Zydus Lifesciences market capitalisation?
Ans. Zydus Lifesciences has a market capitalisation of Rs 1,15,710.44 crore. This places Zydus Lifesciences Share Price in the Large Cap category and makes even a small percentage move significant in value terms.
Is Zydus Lifesciences Share Price expensive by valuation?
Ans. Zydus Lifesciences Share Price trades at a P/E of 25.51 and a P/B of 4.27. Against the industry median P/E of 31.87, the earnings multiple looks lower, while P/B is close to the industry average.
How does Zydus Lifesciences compare with healthcare peers?
Ans. Zydus Lifesciences Share Price compares well on profitability, with ROE of 19.69% and ROCE of 21.39%. Its market cap is below Sun Pharma and Divi's Laboratories, but above several other listed drug makers.
What do ROE and ROCE show for Zydus Lifesciences?
Ans. ROE of 19.69% shows returns generated on shareholder equity, while ROCE of 21.39% shows returns on capital employed. Both figures stand above the healthcare industry median, supporting the Zydus Lifesciences Share Price debate.
What do EPS and book value mean for Zydus Lifesciences Share Price?
Ans. EPS of Rs 45.24 reflects earnings attributable to each share, while book value of Rs 270.31 reflects accounting net worth per share. These numbers help frame Zydus Lifesciences Share Price against fundamentals.
Where can investors track Zydus Lifesciences Share Price and market context?
Ans. Investors can track Zydus Lifesciences Share Price on Univest for live price movement, valuation ratios, sector context and 52-week levels. It is a practical way to follow Zydus Lifesciences Share Price Today and broader stock analysis.
